Ciliary body melanoma
This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (June 2014) |
Ciliary body melanoma is a type of cancer arising from the coloured part (uvea) of the eye.
About 12% of uveal melanoma arise from the ciliary body.
Clinical features[]
It occurs most commonly in the sixth decade of life.
- External signs include dilated blood vessels (sentinel vessels). Extraocular erosion may produce a dark mass beneath the conjunctiva.
- Pressure on the lens by the enlarging tumor can cause astigmatism, of the lens and formation of a localised lens opacity.
- The tumor can erode forward through the iris root and mimic an iris melanoma.
- Retinal detachment can be rarely caused by posterior extension of the tumor.
- Anterior uveitis is an uncommon presentation and occurs due to tumor necrosis.
- Cirumferentially growing tumors carry a bad prognosis as they are diagnosed late.
- At times the tumor is detected as an incidental finding during routine examination.
The tumour is usually diagnosed by clinical examination with a slit-lamp utilising a triple mirror contact lens. Ultrasonography and fine-needle aspiration biopsy (FNAB) are also sometimes helpful in confirming the diagnosis.
Treatment[]
Enucleation (surgical removal of the eye) is the treatment of choice for large ciliary body melanomas. Small or medium sized tumors may be treated by an . Radiotherapy may be appropriate in selected cases.
See also[]
- Ocular oncology
- Uveal melanoma – melanoma of the eye
References[]
- Ciliary Body Melanoma - Springer
- Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy
- Microvascular Density in Predicting Survival of Patients with Choroidal and Ciliary Body Melanoma
- Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma
- Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays)
- Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary... - Abstract - Europe PubMed Central
Categories:
- Ocular neoplasia